Pharmaceutical companies paid £454.5 million to healthcare professionals and organisations in the UK in 2016, an increase of 25 per cent compared with 2015, the industry trade association has said.
The rise was driven by a 33 per cent rise in payments relating to R&D since 2015, from £254m in 2015 to £338m in 2016.
Overall, 74 per cent of payments to healthcare professionals and organisations in 2016 were related to R&D, according to data published on 30 June by the Association of the British Pharmaceutical Industry (ABPI).
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.